CYCC : Summary for Cyclacel Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 5 hrs 55 mins

Cyclacel Pharmaceuticals, Inc. (CYCC)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.32+0.23 (+4.52%)
As of 10:05AM EST. Market open.
People also watch
SNSSAEZSCYTXGNVCOPXA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close5.09
Open5.40
Bid5.36 x 300
Ask5.47 x 900
Day's Range5.20 - 5.76
52 Week Range3.05 - 9.72
Volume32,716
Avg. Volume157,134
Market Cap15.39M
Beta4.66
PE Ratio (TTM)-1.27
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire15 days ago

    Cyclacel Pharmaceuticals to Present at the 19th Annual BIO CEO & Investor Conference

    BERKELEY HEIGHTS, N.J., Feb. 06, 2017-- Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer ...

  • Capital Cubelast month

    ETFs with exposure to Cyclacel Pharmaceuticals, Inc. : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Cyclacel Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CYCC-US. Comparing the performance and risk of Cyclacel Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Cyclacel Pharmaceuticals, Inc. : December 13, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Cyclacel Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CYCC-US. Comparing the performance and risk of Cyclacel Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)